HRT Financial’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-124,884
Closed -$261K 2793
2023
Q3
$261K Sell
124,884
-17,566
-12% -$40.9K ﹤0.01% 1724
2023
Q2
$327K Sell
142,450
-21,369
-13% -$47.1K ﹤0.01% 1576
2023
Q1
$353K Sell
163,819
-15,383
-9% -$35.2K ﹤0.01% 1615
2022
Q4
$367K Buy
+179,202
New +$396K 0.01% 1617
2022
Q1
Sell
-42,945
Closed -$115K 3563
2021
Q4
$115K Sell
42,945
-63,134
-60% -$211K ﹤0.01% 2722
2021
Q3
$402K Sell
106,079
-14,665
-12% -$55.7K ﹤0.01% 2205
2021
Q2
$513K Buy
+120,744
New +$520K ﹤0.01% 1747
2021
Q1
Sell
-23,332
Closed -$122K 2977
2020
Q4
$122K Buy
+23,332
New +$134K ﹤0.01% 1601
2020
Q1
Sell
-18,700
Closed -$126K 1134
2019
Q4
$126K Buy
+18,700
New +$141K 0.01% 1002

Other funds holding MNOV

HRT Financial's MNOV Position: Q4 2023 in Review

HRT Financial sold out of MediciNova (MNOV) in Q4 2023, closing a stake of 124,884 shares — an estimated $261K sold.

HRT Financial first reported a position in MNOV in Q4 2019 and held it in 9 quarters. The position peaked at $513K in Q2 2021. 34 funds tracked by Wall St. Rank hold MNOV as of Q4 2023.

  • HRT Financial reported no remaining MediciNova position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 124,884 MediciNova shares in Q4 2023, an estimated $261K.
  • HRT Financial first reported a position in MediciNova in Q4 2019 and held it in 9 quarters.
  • HRT Financial's MediciNova position peaked at $513K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held MediciNova as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.